Suppr
超能文献

Ethical issues and concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors.

作者信息

Liumbruno Giancarlo Maria, Petrini Carlo

出版信息

Blood Transfus. 2012 Oct;10(4):550-2. doi: 10.2450/2012.0136-11. Epub 2012 Mar 29.

DOI:10.2450/2012.0136-11

PMID:22507862

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3496227/

Abstract

摘要

相似文献

Ethical issues and concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors.

Blood Transfus. 2012 Oct;10(4):550-2. doi: 10.2450/2012.0136-11. Epub 2012 Mar 29.

Transfusion. 2015 Feb;55(2):229-31. doi: 10.1111/trf.12961.

Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance.

Transfusion. 2016 Dec;56(12):3055-3064. doi: 10.1111/trf.13853. Epub 2016 Sep 16.

Biol Blood Marrow Transplant. 2016 Feb;22(2):277-283. doi: 10.1016/j.bbmt.2015.08.033. Epub 2015 Sep 4.

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.

Cytotherapy. 2015 Oct;17(10):1485-93. doi: 10.1016/j.jcyt.2015.05.010. Epub 2015 Jul 15.

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.

Bone Marrow Transplant. 2019 Jun;54(6):858-866. doi: 10.1038/s41409-018-0350-y. Epub 2018 Oct 3.

The use of granulocyte colony stimulating factoR (G-CSF) (filgrastim) alone in the mobilization of stem cell in the autologous stem cell transplantation.

Transfus Apher Sci. 2013 Aug;49(1):97-9. doi: 10.1016/j.transci.2013.02.044. Epub 2013 Jul 3.

The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.

Transfus Apher Sci. 2013 Jun;48(3):315-20. doi: 10.1016/j.transci.2013.04.007. Epub 2013 Apr 20.

Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors.

Transfus Apher Sci. 2016 Jun;54(3):410-5. doi: 10.1016/j.transci.2016.03.003. Epub 2016 Mar 24.

Ann Hematol. 2017 Oct;96(10):1735-1739. doi: 10.1007/s00277-017-3060-4. Epub 2017 Aug 11.

引用本文的文献

Hematopoietic Stem Cell Donors' Experiences of Information and Side-Effects During the First Year After Donation-A Swedish National Study.

J Clin Apher. 2025 Aug;40(4):e70050. doi: 10.1002/jca.70050.

We have a specific duty to maximise the safety of related donors.

Blood Transfus. 2012 Oct;10(4):407-10. doi: 10.2450/2012.0042-12. Epub 2012 Jul 12.

本文引用的文献

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association.

Haematologica. 2011 Jul;96(7):942-7. doi: 10.3324/haematol.2011.045740.

Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation.

Haematologica. 2011 Jul;96(7):937-42. doi: 10.3324/haematol.2011.041210.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Ethical issues and concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译